Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02251548 |
Title | A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia |
Acronym | iFCR |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Dana-Farber Cancer Institute, Pharmacyclics |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Miami Sylvester Comprehensive Cancer Center | Coral Gables | Florida | 33146 | United States | Details | |
University of Miami Sylvester Comprehensive Cancer Center | Deerfield Beach | Florida | 33442 | United States | Details | |
Unversity of Miami Sylvester Comprehensve Cancer Center | Miami | Florida | 33136 | United States | Details | |
University of Kansas Cancer Center | Westwood | Kansas | 66205 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
West Michigan Cancer Center | Kalamazoo | Michigan | 49007 | United States | Details | |
Duke University Medical Center | Durham | North Carolina | 27710 | United States | Details |